| User's Publication |
|
20382
Fan M, Arai M, Tawada A, Chiba T, Fukushima R, Uzawa K, Shiiba M, Kato N, Tanzawa H, Takiguchi Y.
Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancers.
Oncol Rep
2022
47(1)
PubMed ID: 34738627
DOI: 10.3892/or.2021.8216
|
|
20513
Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y.
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
Oncoimmunology
2022
11(1):2021619
PubMed ID: 35003900
DOI: 10.1080/2162402X.2021.2021619
|
|
20544
Matsuda R, Sakagami H, Amano S, Iijima Y, Sano M, Uesawa Y, Tamura N, Oishi Y, Takeshima H.
Inhibition of Neurotoxicity/Anticancer Activity of Bortezomib by Caffeic Acid and Chlorogenic Acid.
Anticancer Res
2022
42(2):781-790
PubMed ID: 35093876
DOI: 10.21873/anticanres.15536
|
|
20559
Komatsu M, Saito K, Miyamoto I, Koike K, Iyoda M, Nakashima D, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis.
Oncol Lett
2022
23(2):49
PubMed ID: 34992682
DOI: 10.3892/ol.2021.13167
|
|
16180
Katsuhiro Asaka, Akira Fukatsu, Chiaki Komine
The Effectiveness of a Portable Fluorescence Spectrophotometer for Early Detection of Oral Cancer
Open Journal of Stomatology
2022
12:30-31
DOI: 10.4236/ojst.2022.121003
|
|
16203
Sasabe E, Tomomura A, Liu H, Sento S, Kitamura N, Yamamoto T.
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis
Cancer Sci
2022
113(2):609-621
PubMed ID: 34874595
DOI: 10.1111/cas.15225
|
|
20638
Shahbaz K, Asif JA, Liszen T, Nurul AA, Alam MK.
Cytotoxic and Antioxidant Effects of Phoenix dactylifera L. (Ajwa Date Extract) on Oral Squamous Cell Carcinoma Cell Line.
Biomed Res Int
2022
2022:5792830
PubMed ID: 35233390
DOI: 10.1155/2022/5792830
|
|
20648
Naitoh K, Orihara Y, Sakagami H, Miura T, Satoh K, Amano S, Bandow K, Iijima Y, Kurosaki K, Uesawa Y, Hashimoto M, Wakabayashi H.
Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives.
Int J Mol Sci
2022
23(5)
PubMed ID: 35269748
DOI: 10.3390/ijms23052601
|
|
20658
Tabata A, Shirai R, Miki H, Nishikawa Y, Kashima T, Aoyama T, Murakami S, Azuma M, Tomoyasu T, Nagamune H.
Hapten-labeled fusion-polymerase chain reaction of multiple marker genes for the application of immunochromatographic test.
J Biosci Bioeng
2022
PubMed ID: 35450786
DOI: 10.1016/j.jbiosc.2022.03.006
|
|
20815
Hossain M, Roayapalley PK, Sakagami H, Satoh K, Bandow K, Das U, Dimmock JR.
Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells.
Medicines (Basel)
2022
9(6)
PubMed ID: 35736248
DOI: 10.3390/medicines9060035
|
|
20884
Shindo A, Kusano M, Sakagami H, Amano S, Inomata M, Abe M, Okazawa M, Ooka T.
Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells.
In Vivo
2022
36(5):2116-2125
PubMed ID: 36099100
DOI: 10.21873/invivo.12937
|
|
13361
Luo F, Sugita H, Muraki K, Saeki S, Chaipech S, Pongpiriyadacha Y, Muraoka O, Morikawa T.
Anti-proliferative activities of coumarins from the Thai medicinal plant Mammea siamensis (Miq.) T. Anders. against human digestive tract carcinoma cell lines.
Fitoterapia
2021
PubMed ID: 33246033
DOI: 10.1016/j.fitote.2020.104780
|
|
20020
Shishido K, Kuroishi T, Sugawara S.
P2 purinergic receptor signaling and interleukin-1 synergistically induce interleukin-6 production in a human oral squamous carcinoma cell line.
J Oral Biosci
2021
PubMed ID: 33497843
DOI: 10.1016/j.job.2021.01.004
|
|
13580
Matsumoto A, Tabata A, Ohkura K, Oda H, Kodama C, Ohkuni H, Takao A, Kikuchi K, Tomoyasu T, Nagamune H.
Molecular characteristics of an adhesion molecule containing cholesterol-dependent cytolysin-motif produced by mitis group streptococci
Microbiol Immunol
2021
65(2):61-75
PubMed ID: 33331679
DOI: 10.1111/1348-0421.12868
|
|
20085
Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto JI, Toeda Y, Okubo M, Eizuka K, Ando T, Nobuchi T, Kawasaki K, Saito T, Iyoda M, Nakashima D, Kasamatsu A, Tanzawa H.
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Sci Rep
2021
11(1):5897
PubMed ID: 33723306
DOI: 10.1038/s41598-021-85242-1
|
|
13776
Hamilton KL, Sheehan SA, Retzbach EP, Timmerman CA, Gianneschi GB, Tempera PJ, Balachandran P, Goldberg GS.
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways
J Cancer Res Clin Oncol
2021
147(2):445-457
PubMed ID: 33205348
DOI: 10.1007/s00432-020-03456-8
|
|
20350
Haga K, Yamazaki M, Maruyama S, Kawaharada M, Suzuki A, Hoshikawa E, Chan NN, Funayama A, Mikami T, Kobayashi T, Izumi K, Tanuma JI.
Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-β/SOX9 axis in cancer progression.
Transl Oncol
2021
14(12):101236
PubMed ID: 34624685
DOI: 10.1016/j.tranon.2021.101236
|
|
15868
Itashiki Y, Harada K, Takenawa T, Ferdous T, Ueyama Y, Mishima K.
Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
Oncol Lett
2021
22(4):730
PubMed ID: 34429770
DOI: 10.3892/ol.2021.12991
|
|
20455
Harada K, Ferdous T, Mishima K.
Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells.
Anticancer Res
2021
41(12):6039-6049
PubMed ID: 34848458
DOI: 10.21873/anticanres.15423
|
|
16099
Saito K, Mitsui A, Sumardika IW, Yokoyama Y, Sakaguchi M, Kondo E.
PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1
Int J Oncol
2021
58(6):29
PubMed ID: 33887877
DOI: 10.3892/ijo.2021.5209
|
|
16112
Akyu Takei R, Tomihara K, Yamazaki M, Moniruzzaman R, Heshiki W, Sekido K, Tachinami H, Sakurai K, Yonesi A, Imaue S, Fujiwara K, Noguchi M.
Protumor role of estrogen receptor expression in oral squamous cell carcinoma cells
Oral Surg Oral Med Oral Pathol Oral Radiol
2021
132(5):549-565
PubMed ID: 34518137
DOI: 10.1016/j.oooo.2021.04.006
|
|
16136
Harada K, Ferdous T, Watanabe K, Mizukami Y, Mishima K.
Effects of an elemental diet, Elental®, may differ between healthy oral cells and oral cancer cells
Oncol Rep
2021
45(2):738-751
PubMed ID: 33416174
DOI: 10.3892/or.2020.7896
|
|
16139
Kase-Kato I, Asai S, Minemura C, Tsuneizumi K, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Molecular Pathogenesis of the Coronin Family: CORO2A Facilitates Migration and Invasion Abilities in Oral Squamous Cell Carcinoma
Int J Mol Sci
2021
22(23):12684
PubMed ID: 34884487
DOI: 10.3390/ijms222312684
|
|
16174
Roayapalley PK, Dimmock JR, Contreras L, Balderrama KS, Aguilera RJ, Sakagami H, Amano S, Sharma RK, Das U.
Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts
Molecules
2021
26(23):7132
PubMed ID: 34885719
DOI: 10.3390/molecules26237132
|
|
16195
Yamali C, Sakagami H, Uesawa Y, Kurosaki K, Satoh K, Masuda Y, Yokose S, Ece A, Bua S, Angeli A, Supuran CT, Gul HI.
Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides
Eur J Med Chem
2021
217:113351
PubMed ID: 33744685
DOI: 10.1016/j.ejmech.2021.113351
|
|
16196
Sakagami H, Furukawa T, Satoh K, Amano S, Iijima Y, Koshikawa T, Asai D, Fukuchi K, Takemura H, Kanamoto T, Yokose S.
Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue
Medicines (Basel)
2021
8(7):33
PubMed ID: 34206186
DOI: 10.3390/medicines8070033
|
|
16200
Roayapalley PK, Sakagami H, Satoh K, Amano S, Bandow K, Aguilera RJ, Hernandez KGC, Schiaffino Bustamante AY, Dimmock SG, Sharma RK, Das U, Dimmock JR.
Cytotoxic Tumour-Selective 1,5-Diaryl-3-Oxo-1,4-Pentadienes Mounted on a Piperidine Ring
Medicines (Basel)
2021
8(12):78
PubMed ID: 34940290
DOI: 10.3390/medicines8120078
|
|
16206
Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
Int J Mol Sci
2021
22(18):9947
PubMed ID: 34576110
DOI: 10.3390/ijms22189947
|
|
16862
Kawasaki M, Sakabe T, Kodani I, Umekita Y.
Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma
Anticancer Res
2021
41(9):4563-4570
PubMed ID: 34475084
DOI: 10.21873/anticanres.15269
|
|
16975
Hotta H, Hamamura K, Shibuya H, Ohmi Y, Furukawa K, Furukawa K.
Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling
Anticancer Res
2021
41(4):1821-1830
PubMed ID: 33813387
DOI: 10.21873/anticanres.14948
|
|
11844
Sakurai K, Tomihara K, Yamazaki M, Heshiki W, Moniruzzaman R, Sekido K, Tachinami H, Ikeda A, Imaue S, Fujiwara K, Noguchi M.
CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity.
Oral Dis
2020
26(4):745-755
PubMed ID: 31603606
DOI: 10.1111/odi.13210
|
|
6954
Hayashi H, Chiba T, Mihara-Tomiyama N, Negishi T, Kodama Y, Sakashita H, Imai K.
Domain structures of mucosa-associated lymphoid tissue lymphoma translocation 1 protein for nuclear localization in oral carcinoma cells and the proliferation inhibition.
Biochem Biophys Res Commun
2020
522(3):799-804
PubMed ID: 31791579
DOI: 10.1016/j.bbrc.2019.11.171
|
|
11965
Fujii S, Tajiri Y, Hasegawa K, Matsumoto S, Yoshimoto RU, Wada H, Kishida S, Kido MA, Yoshikawa H, Ozeki S, Kiyoshima T.
The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation.
Lab. Invest.
2020
PubMed ID: 31857698
DOI: 10.1038/s41374-019-0357-z
|
|
12037
Nakagawa F, Higashi S, Ando E, Ohsumi T, Watanabe S, Takeuchi H.
Modification of TRPV4 activity by acetaminophen.
Heliyon
2020
PubMed ID: 32051870
DOI: 10.1016/j.heliyon.2020.e03301
|
|
13013
Nakaya G, Sakagami H, Koga-Ogawa Y, Shiroto A, Nobesawa T, Ueda D, Nakatani S, Kobata K, Iijima Y, Tone S, David-Gonzalez A, Garcia-Contreras R, Tomomura M, Kito S, Tamura N, Takeshima H.
Augmentation of Neurotoxicity of Anticancer Drugs by X-Ray Irradiation.
In Vivo
2020
PubMed ID: 32354886
DOI: 10.21873/invivo.11869
|
|
13093
Iijima Y, Bandow K, Amano S, Sano M, Hino S, Kaneko T, Horie N, Sakagami H.
Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
Anticancer Res
2020
PubMed ID: 32620607
DOI: 10.21873/anticanres.14357
|
|
13205
Teratani M, Nakamura S, Sakagami H, Fujise M, Hashimoto M, Okudaira N, Bandow K, Iijima Y, Nagai J, Uesawa Y, Wakabayashi H.
Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro.
Anticancer Res
2020
PubMed ID: 32878776
DOI: 10.21873/anticanres.14491
|
|
13427
Thahomina Khan, Kazunori Igarashi, Ami Tanabe, Taiki Miyazawa, Shigeto Fukushima, Yutaka Miura, Yu Matsumoto, Tatsuya Yamasoba, Akira Matsumoto, Horacio Cabral, and Kazunori Kataoka
Structural Control of Boronic Acid Ligands Enhances Intratumoral Targeting of Sialic Acid To Eradicate Cancer Stem-like Cells
ACS Appl. Bio Mater.
2020
DOI: 10.1021/acsabm.0c00530
|
|
13775
Al-Tayar BA, Ahmad A, Yusoff ME, Abdullah SF, Mohamad NK, Md Hashim SN, Kishida S, Kishida M, Nakamura N, Kibe T, Harun MH.
Cytotoxic Effects of Betel Quid and Areca Nut Aqueous Extracts on Mouse Fibroblast, Human Mouth-Ordinary-Epithelium 1 and Human Oral Squamous Cell Carcinoma Cell Lines
Asian Pac J Cancer Prev
2020
21(4):1005-1009
PubMed ID: 32334462
DOI: 10.31557/APJCP.2020.21.4.1005
|
|
13783
Otsuki Y, Yamasaki J, Suina K, Okazaki S, Koike N, Saya H, Nagano O.
Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy
Cancer Sci
2020
111(1):127-136.
PubMed ID: 31692172
DOI: 10.1111/cas.14224
|
|
13853
Rizwan Mahmood, Jawaad Ahmed Asif, Wan Nazatul, Shima Shahidan
Stingless-bee (Trigona itama) honey adversely impacts the growth of oral squamous cell carcinoma cell lines (HSC-2)
European Journal of Integrative Medicine
2020
37
DOI: 10.1016/j.eujim.2020.101162
|
|
13903
Aika Tanzawa et al.
Comprehensive gene expression analysis of semaphorins in oral squamous cell carcinoma
Oral Science International
2020
17(2):67-72
DOI: 10.1002/osi2.1044
|
|
11300
Shimizu R, Ibaragi S, Eguchi T, Kuwajima D, Kodama S, Nishioka T, Okui T, Obata K, Takabatake K, Kawai H, Ono K, Okamoto K, Nagatsuka H, Sasaki A.
Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
Int. J. Oncol.
2019
PubMed ID: 30431077
DOI: 10.3892/ijo.2018.4631
|
|
11354
Nakamura Y, Nakahata S, Kondo Y, Izumi A, Yamamoto K, Ichikawa T, Tamura T, Noumi K, Yamashita Y, Morishita K.
Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 30587341
DOI: 10.1016/j.bbrc.2018.12.066
|
|
11363
Nishioka T, Tada H, Ibaragi S, Chen C, Sasano T.
Nicotine exposure induces the proliferation of oral cancer cells through the α7 subunit of the nicotinic acetylcholine receptor.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 30598264
DOI: 10.1016/j.bbrc.2018.12.154
|
|
11620
Imanari K, Hashimoto M, Wakabayashi H, Okudaira N, Bandow K, Nagai J, Tomomura M, Tomomura A, Uesawa Y, Sakagami H.
Quantitative Structure-Cytotoxicity Relationship of Azulene Amide Derivatives.
Anticancer Res.
2019
PubMed ID: 31262875
DOI: 10.21873/anticanres.13497
|
|
6911
Tabata A, Yamada T, Ohtani H, Ohkura K, Tomoyasu T, Nagamune H.
β-Hemolytic Streptococcus anginosus subsp. anginosus causes streptolysin S-dependent cytotoxicity to human cell culture lines in vitro.
J Oral Microbiol
2019
11(1):1609839.
PubMed ID: 31105901
DOI: 10.1080/20002297.2019.1609839
|
|
9696
Kazuya Hiroshima, Masashi Shiiba, Noritoshi Oka, Fumihiko Hayashi, Sho Ishida, Reo Fukushima, Kazuyuki Koike, Manabu Iyoda, Dai Nakashima, Hideki Tanzawa, Katsuhiro Uzawa
Tspan15 Plays a Crucial Role in Metastasis in Oral Squamous Cell Carcinoma
Exp Cell Res
2019
384(2):111622
PubMed ID: 31518558
DOI: 10.1016/j.yexcr.2019.111622
|
|
9726
Mohamed A A Orabi, Esam A Orabi, Shoko Taniguchi, Hiroshi Sakagami, Morio Yoshimura, Yoshiaki Amakura, Tsutomu Hatano
Structures, NMR Spectroscopic Features, and Cytotoxic Properties of Oligomeric Hellinoyl ( m-GO- m-GOG)-Type Ellagitannins From the Galls of Tamarix aphylla
J Nat Prod
2019
82(10):2682-2695
PubMed ID: 31532650
DOI: 10.1021/acs.jnatprod.9b00073
|
|
9890
Noritoshi Oka, Atsushi Kasamatsu, Yosuke Endo-Sakamoto, Keitaro Eizuka, Sho Wagai, Nao Koide-Ishida, Isao Miyamoto, Manabu Iyoda, Hideki Tanzawa, Katsuhiro Uzawa
Centromere Protein N Participates in Cellular Proliferation of Human Oral Cancer by Cell-Cycle Enhancement
J Cancer
2019
10(16):3728-3734
PubMed ID: 31333790
DOI: 10.7150/jca.32281
|
|
11907
Cervino G, Fiorillo L, Herford AS, Romeo U, Bianchi A, Crimi S, D'Amico C, De Stefano R, Troiano G, Santoro R, Laino L, Laino G, Cicciù M.
Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.
Dis. Markers
2019
PubMed ID: 31019584
DOI: 10.1155/2019/8040361
|
|
11931
Iijima Y, Bandow K, Sano M, Hino S, Kaneko T, Horie N, Sakagami H.
In Vitro Assessment of Antitumor Potential and Combination Effect of Classical and Molecular-targeted Anticancer Drugs.
Anticancer Res.
2019
PubMed ID: 31810932
DOI: 10.21873/anticanres.13882
|
|
11933
Nagai J, Shi H, Sezaki N, Yoshida N, Bandow K, Uesawa Y, Sakagami H, Tomomura M, Tomomura A, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones.
Anticancer Res.
2019
PubMed ID: 31810912
DOI: 10.21873/anticanres.13862
|
|
12456
Bilginer S, Gul HI, Erdal FS, Sakagami H, Levent S, Gulcin I, Supuran CT.
Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2( 3H)-benzoxazolones
J Enzyme Inhib Med Chem
2019
34(1):1722-1729
PubMed ID: 31576761
DOI: 10.1080/14756366.2019.1670657
|
|
12457
Eizuka K, Nakashima D, Oka N, Wagai S, Takahara T, Saito T, Koike K, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
J Cancer
2019
10(20):4913-4920
PubMed ID: 31598163
DOI: 10.7150/jca.32582
|
|
12458
Okazaki S, Umene K, Yamasaki J, Suina K, Otsuki Y, Yoshikawa M, Minami Y, Masuko T, Kawaguchi S, Nakayama H, Banno K, Aoki D, Saya H, Nagano O.
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma
Cancer Sci
2019
110(11):3453-3463
PubMed ID: 31444923
DOI: 10.1111/cas.14182
|
|
12586
Sato K, Shi L, Ito F, Ohara Y, Motooka Y, Tanaka H, Mizuno M, Hori M, Hirayama T, Hibi H, Toyokuni S.
Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner
J Clin Biochem Nutr
2019
65(1):8-15
PubMed ID: 31379408
DOI: 10.3164/jcbn.18-91
|
|
16176
Kawano S, Ito K, Yahata K, Kira K, Abe T, Akagi T, Asano M, Iso K, Sato Y, Matsuura F, Ohashi I, Matsumoto Y, Isomura M, Sasaki T, Fukuyama T, Miyashita Y, Kaburagi Y, Yokoi A, Asano O, Owa T, Kishi Y.
A landmark in drug discovery based on complex natural product synthesis
Sci Rep
2019
9(1):8656
PubMed ID: 31209263
DOI: 10.1038/s41598-019-45001-9
|
|
16194
Yamali C, Gul HI, Ece A, Bua S, Angeli A, Sakagami H, Sahin E, Supuran CT.
Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors
Bioorg Chem
2019
92:103222.
PubMed ID: 31499260
DOI: 10.1016/j.bioorg.2019.103222
|
|
10618
Ziauddin SM, Yoshimura A, Montenegro Raudales JL, Ozaki Y, Higuchi K, Ukai T, Kaneko T, Miyazaki T, Latz E, Hara Y.
Crystalline structure of pulverized dental calculus induces cell death in oral epithelial cells.
J. Periodont. Res.
2018
53:353-361
PubMed ID: 29159877
DOI: 10.1111/jre.12520
|
|
10682
Yamamoto JI, Kasamatsu A, Okubo Y, Nakashima D, Fushimi K, Minakawa Y, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Evaluation of tryptophan-aspartic acid repeat-containing protein 34 as a novel tumor-suppressor molecule in human oral cancer.
Biochem. Biophys. Res. Commun.
2018
495:2469-2474
PubMed ID: 29278705
DOI: 10.1016/j.bbrc.2017.12.138
|
|
10683
Suzuki S, Hoshino H, Yoshida K, Nakanishi J, Tsuchiya-Hirata S, Kobuke S, Haruyama N, Nishimura F, Shiba H.
Genome-wide identification of chromatin-enriched RNA reveals that unspliced dentin matrix protein-1 mRNA regulates cell proliferation in squamous cell carcinoma.
Biochem. Biophys. Res. Commun.
2018
495:2303-2309
PubMed ID: 29278708
DOI: 10.1016/j.bbrc.2017.12.136
|
|
10724
Uesawa Y, Sakagami H, Okudaira N, Toda K, Takao K, Kagaya H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
Anticancer Res.
2018
38:817-823
PubMed ID: 29374707
DOI: 10.21873/anticanres.12289
|
|
10727
Sakagami H, Okudaira N, Uesawa Y, Takao K, Kagaya H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 2-Azolylchromones.
Anticancer Res.
2018
38:763-770
PubMed ID: 29374700
DOI: 10.21873/anticanres.12282
|
|
10806
Okubo Y, Kasamatsu A, Yamatoji M, Fushimi K, Ishigami T, Shimizu T, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression.
Exp. Cell Res.
2018
367:112-118
PubMed ID: 29614312
DOI: 10.1016/j.yexcr.2018.03.041
|
|
10829
Wada T, Maruyama R, Irie Y, Hashimoto M, Wakabayashi H, Okudaira N, Uesawa Y, Kagaya H, Sakagami H.
In Vitro Anti-tumor Activity of Azulene Amide Derivatives.
In Vivo
2018
32:479-486
PubMed ID: 29695549
DOI: 10.21873/invivo.11264
|
|
11086
Uesawa Y, Sakagami H, Shi H, Hirose M, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Furo[2,3-b]chromones.
Anticancer Res.
2018
38(6):3283-3290
PubMed ID: 29848675
DOI: 10.21873/anticanres.12593
|
|
11110
Hara Y, Sakagami H, Shi H, Abe T, Tamura N, Takeshima H, Horie N, Kaneko T, Shiratsuchi H, Kaneko T.
Partial Protection of Paclitaxel-induced Neurotoxicity by Antioxidants.
In Vivo
2018
32(4):745-752
PubMed ID: 29936454
DOI: 10.21873/invivo.11303
|
|
11115
Shi H, Nagai J, Sakatsume T, Bandow K, Okudaira N, Sakagami H, Tomomura M, Tomomura A, Uesawa Y, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 2-(N-cyclicamino)chromone Derivatives.
Anticancer Res.
2018
38(7):3897-3906
PubMed ID: 29970510
DOI: 10.21873/anticanres.12674
|
|
11147
Nagai J, Shi H, Kubota Y, Bandow K, Okudaira N, Uesawa Y, Sakagami H, Tomomura M, Tomomura A, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Pyrano[4,3-b]chromones.
Anticancer Res.
2018
38(8):4449-4457
PubMed ID: 30061209
DOI: 10.21873/anticanres.12747
|
|
11148
Shi H, Nagai J, Sakatsume T, Bandow K, Okudaira N, Uesawa Y, Sakagami H, Tomomura M, Tomomura A, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 3-(N-Cyclicamino)chromone Derivatives.
Anticancer Res.
2018
38(8):4459-4467
PubMed ID: 30061210
DOI: 10.21873/anticanres.12748
|
|
11192
Miyaguchi J, Shiga K, Ogawa K, Suzuki F, Katagiri K, Saito D, Ikeda A, Horii A, Watanabe M, Igimi S.
Treatment with Lactobacillus Retards the Tumor Growth of Head and Neck Squamous Cell Carcinoma Cells Inoculated in Mice.
Tohoku J. Exp. Med.
2018
245(4):269-275
PubMed ID: 30158369
DOI: 10.1620/tjem.245.269
|
|
11226
Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.
J Cancer
2018
PubMed ID: 30271493
DOI: 10.7150/jca.25666
|
|
11272
Sakagami H, Sugimoto M, Kanda Y, Murakami Y, Amano O, Saitoh J, Kochi A.
Changes in Metabolic Profiles of Human Oral Cells by Benzylidene Ascorbates and Eugenol.
Medicines (Basel)
2018
PubMed ID: 30384403
DOI: 10.3390/medicines5040116
|
|
4078
Halise Inci, Cem Yamali, Gulsen Gunesacar, Hiroshi Sakagami, Noriyuki Okudaira, Yoshihiro Uesawa, Hajime Kagaya
Cytotoxicity, apoptosis, and QSAR studies of phenothiazine derived methoxylated chalcones as anticancer drug candidates
Medicinal Chemistry Research
2018
27:2366–2378
DOI: 10.1007/s00044-018-2242-5
|
|
4173
Uehara M, Minemura H, Ohno T, Hashimoto M, Wakabayashi H, Okudaira N, Sakagami H.
In Vitro Antitumor Activity of Alkylaminoguaiazulenes.
In Vivo
2018
PubMed ID: 29695558
DOI: 10.21873/invivo.11273
|
|
4235
Okazaki S, Shintani S, Hirata Y, Suina K, Semba T, Yamasaki J, Umene K, Ishikawa M, Saya H, Nagano O.
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Oncotarget
2018
PubMed ID: 30333913
DOI: 10.18632/oncotarget.26112
|
|
4236
Nanbu T, Umemura N, Ohkoshi E, Nanbu K, Sakagami H, Shimada J.
Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
Oncol. Rep.
2018
PubMed ID: 29192320
DOI: 10.3892/or.2017.6105
|
|
4237
Yamanouchi R, Harada K, Ferdous T, Ueyama Y.
Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma.
Mol Clin Oncol
2018
PubMed ID: 29456845
DOI: 10.3892/mco.2018.1548
|
|
4239
Hong Y, He H, Sui W, Zhang J, Zhang S, Yang D.
Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Int. J. Oncol.
2018
PubMed ID: 29344674
DOI: 10.3892/ijo.2018.4247
|
|
14708
Arimoto T, Yambe R, Morisaki H, Umezawa H, Kataoka H, Matsui S, Kuwata H.
Influence of excess branched-chain amino acid uptake by Streptococcus mutans in human host cells
FEMS Microbiol Lett
2018
365(3)
PubMed ID: 29240953
DOI: 10.1093/femsle/fnx273
|
|
14912
Yun MR, Choi HM, Kang HN, Lee Y, Joo HS, Kim DH, Kim HR, Hong MH, Yoon SO, Cho BC.
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma
Oncogene
2018
37(3):377-388
PubMed ID: 28945228
DOI: 10.1038/onc.2017.339
|
|
10044
Ohkoshi E, Umemura N.
Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells.
Int. J. Oncol.
2017
50:387-395
PubMed ID: 28035370
DOI: 10.3892/ijo.2016.3821
|
|
10148
Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Exp. Cell Res.
2017
352:357-363
PubMed ID: 28237246
DOI: 10.1016/j.yexcr.2017.02.026
|
|
10155
Koide N, Kasamatsu A, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
Sci Rep
2017
7:43379
PubMed ID: 28230172
DOI: 10.1038/srep43379
|
|
10191
Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Biochem. Biophys. Res. Commun.
2017
486:385-390
PubMed ID: 28315328
DOI: 10.1016/j.bbrc.2017.03.050
|
|
10197
Sakagami H, Okudaira N, Masuda Y, Amano O, Yokose S, Kanda Y, Suguro M, Natori T, Oizumi H, Oizumi T.
Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
Anticancer Res.
2017
37:1023-1029
PubMed ID: 28314260
DOI: 10.21873/anticanres.11412
|
|
10201
Sakagami H, Masuda Y, Tomomura M, Yokose S, Uesawa Y, Ikezoe N, Asahara D, Takao K, Kanamoto T, Terakubo S, Kagaya H, Nakashima H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Chalcones.
Anticancer Res.
2017
37:1091-1098
PubMed ID: 28314269
DOI: 10.21873/anticanres.11421
|
|
10206
Shimozu Y, Kimura Y, Esumi A, Aoyama H, Kuroda T, Sakagami H, Hatano T.
Ellagitannins of Davidia involucrata. I. Structure of Davicratinic Acid A and Effects of Davidia Tannins on Drug-Resistant Bacteria and Human Oral Squamous Cell Carcinomas.
Molecules
2017
22:
PubMed ID: 28294988
DOI: 10.3390/molecules22030470
|
|
10241
Saijo R, Sekiya H, Tamai E, Kurihara KI, Maki J, Sakagami H, Kawase M.
A Novel Methodology for Synthesis of 1,5,6-Trisubstituted 2(1H)-Pyrazinones of Biological Interest.
Chem. Pharm. Bull.
2017
65:365-372
PubMed ID: 28381677
DOI: 10.1248/cpb.c16-00830
|
|
10384
Miyano K, Cabral H, Miura Y, Matsumoto Y, Mochida Y, Kinoh H, Iwata C, Nagano O, Saya H, Nishiyama N, Kataoka K, Yamasoba T.
cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
J Control Release
2017
261:275-286
PubMed ID: 28666729
DOI: 10.1016/j.jconrel.2017.06.021
|
|
10386
Suzuki R, Sakagami H, Amano S, Fukuchi K, Sunaga K, Kanamoto T, Terakubo S, Nakashima H, Shirataki Y, Tomomura M, Masuda Y, Yokose S, Tomomura A, Watanabe H, Okawara M, Matahira Y.
Evaluation of Biological Activity of Mastic Extracts Based on Chemotherapeutic Indices.
In Vivo
2017
31:591-598
PubMed ID: 28652425
DOI: 10.21873/invivo.11099
|
|
10395
Takada H, Ibaragi S, Eguchi T, Okui T, Obata K, Masui M, Morisawa A, Takabatake K, Kawai H, Yoshioka N, Hassan NMM, Shimo T, Hu GF, Nagatsuka H, Sasaki A.
Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma.
Int. J. Oncol.
2017
51:625-632
PubMed ID: 28656278
DOI: 10.3892/ijo.2017.4050
|
|
10418
Kita A, Kasamatsu A, Nakashima D, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis.
J Cancer
2017
8:2033-2041
PubMed ID: 28819404
DOI: 10.7150/jca.18714
|
|
10572
Uesawa Y, Sakagami H, Ikezoe N, Takao K, Kagaya H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Aurones.
Anticancer Res.
2017
37:6169-6176
PubMed ID: 29061798
DOI: 10.21873/anticanres.12066
|
|
10576
Sakagami H, Uesawa Y, Masuda Y, Tomomura M, Yokose S, Miyashiro T, Murai J, Takao K, Kanamoto T, Terakubo S, Kagaya H, Nakashima H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
Anticancer Res.
2017
37:6161-6168
PubMed ID: 29061797
DOI: 10.21873/anticanres.12065
|
|
10579
Obata K, Shimo T, Okui T, Matsumoto K, Takada H, Takabatake K, Kunisada Y, Ibaragi S, Yoshioka N, Kishimoto K, Nagatsuka H, Sasaki A.
Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
Anticancer Res.
2017
37:6119-6123
PubMed ID: 29061792
DOI: 10.21873/anticanres.12060
|
|
10600
Matsuo Y, Shinoda D, Nakamaru A, Kamohara K, Sakagami H, Mimaki Y.
Steroidal Glycosides from Convallaria majalis Whole Plants and Their Cytotoxic Activity.
Int J Mol Sci
2017
18:
PubMed ID: 29112119
DOI: 10.3390/ijms18112358
|
|
11036
Increased Expression of CD44v9, A Cancer Stem Cell Marker, in Head And Neck Squamous Cell Carcinoma Cells after Irradiation
Int J Cancer Oncol
2017
4: 225- 230
DOI: 10.15436/2377-0902.17.1628
|
|
6025
Abé T, Maruyama S, Yamazaki M, Xu B, Babkair H, Sumita Y, Cheng J, Yamamoto T, Saku T.
Proteomic and histopathological characterization of the interface between oral squamous cell carcinoma invasion fronts and non-cancerous epithelia.
Exp Mol Pathol
2017
102(2):327-336
PubMed ID: 28242296
DOI: 10.1016/j.yexmp.2017.02.018
|
|
6026
Morishima H, Washio J, Kitamura J, Shinohara Y, Takahashi T, Takahashi N.
Real-time monitoring system for evaluating the acid-producing activity of oral squamous cell carcinoma cells at different environmental pH.
Sci Rep.
2017
7(1):10092
PubMed ID: 28855722
DOI: 10.1038/s41598-017-10893-y
|
|
6029
Ishida S et al
Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Biochem Biophys Res Commun
2017
483(1):339-345
PubMed ID: 28017725
DOI: 10.1016/j.bbrc.2016.12.142
|
|
12679
Tamura T, Ichikawa T, Nakahata S, Kondo Y, Tagawa Y, Yamamoto K, Nagai K, Baba T, Yamaguchi R, Futakuchi M, Yamashita Y, Morishita K.
Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
Cancer Res
2017
77(9):2363-2374
PubMed ID: 28209617
DOI: 10.1158/0008-5472.CAN-16-2114
|
|
14231
Harada K, Ferdous T, Harada T, Takenawa T, Ueyama Y.
Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
Oncol Lett
2017
14(3):3349-3356.
PubMed ID: 28927087
DOI: 10.3892/ol.2017.6602
|
|
9584
Hino S, Nishiyama A, Matsuta T, Horie N, Shimoyama T, Tanaka S, Sakagami H.
Quest for Cells Responsible for Age-related Increase of Salivary Glycine and Proline.
In Vivo
2016
30:91-7
PubMed ID: 26912818
|
|
9616
Kitajima D, Kasamatsu A, Nakashima D, Miyamoto I, Kimura Y, Saito T, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Tie2 Regulates Tumor Metastasis of Oral Squamous Cell Carcinomas.
J Cancer
2016
7:600-7
PubMed ID: 27053959
DOI: 10.7150/jca.13820
|
|
9630
Kimura Y, Kasamatsu A, Nakashima D, Yamatoji M, Minakawa Y, Koike K, Fushimi K, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.
J Cancer
2016
7:702-10
PubMed ID: 27076852
DOI: 10.7150/jca.14208
|
|
9640
Wang M, Miura Y, Tsuchihashi K, Miyano K, Nagano O, Yoshikawa M, Tanabe A, Makino J, Mochida Y, Nishiyama N, Saya H, Cabral H, Kataoka K.
Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines.
J Control Release
2016
230:26-33
PubMed ID: 27040816
DOI: 10.1016/j.jconrel.2016.03.038
|
|
9694
Harada K, Ferdous T, Harada T, Ueyama Y.
Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Int. J. Oncol.
2016
49:276-84
PubMed ID: 27210058
DOI: 10.3892/ijo.2016.3523
|
|
9770
Harada K, Ferdous T, Cui D, Kuramitsu Y, Matsumoto T, Ikeda E, Okano H, Ueyama Y.
Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.
BMC Cancer
2016
16:548
PubMed ID: 27464948
DOI: 10.1186/s12885-016-2416-9
|
|
9808
Tomikoshi Y, Nomura M, Okudaira N, Sakagami H, Wakabayashi H.
Enhancement of Cytotoxicity of Three Apoptosis-inducing Agents Against Human Oral Squamous Cell Carcinoma Cell Line by Benzoxazinotropone.
In Vivo
2016
30:645-50
PubMed ID: 27566085
|
|
9892
Uesawa Y, Sakagami H, Kagaya H, Yamashita M, Takao K, Sugita Y.
Quantitative Structure-cytotoxicity Relationship of 3-Benzylidenechromanones.
Anticancer Res.
2016
36:5803-5812
PubMed ID: 27793902
DOI: 10.21873/anticanres.11164
|
|
9896
Suzuki R, Matsushima Y, Okudaira N, Sakagami H, Shirataki Y.
Cytotoxic Components Against Human Oral Squamous Cell Carcinoma Isolated from Andrographis paniculata.
Anticancer Res.
2016
36:5931-5935
PubMed ID: 27793918
DOI: 10.21873/anticanres.11180
|
|
9900
Harada K, Ferdous T, Ueyama Y.
Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo.
Anticancer Res.
2016
36:5923-5930
PubMed ID: 27793917
DOI: 10.21873/anticanres.11179
|
|
9911
Fukuchi K, Okudaira N, Adachi K, Odai-Ide R, Watanabe S, Ohno H, Yamamoto M, Kanamoto T, Terakubo S, Nakashima H, Uesawa Y, Kagaya H, Sakagami H.
Antiviral and Antitumor Activity of Licorice Root Extracts.
In Vivo
2016
30:777-785
PubMed ID: 27815461
DOI: 10.21873/invivo.10994
|
|
5809
Ninomiya K et al
Acylated oleanane-type triterpene saponins from the flowers of Bellis perennis show anti-proliferative activities against human digestive tract carcinoma cell lines.
J Nat Med
2016
70(3):435-51
PubMed ID: 27178360
DOI: 10.1007/s11418-016-0998-9
|
|
6032
Tada H, Shimizu T, Nagaoka I, Takada H.
Vitamin D3 analog maxacalcitol (OCT) induces hCAP-18/LL-37 production in human oral epithelial cells.
Biomed Res
2016
37(3):199-205
PubMed ID: 27356607
DOI: 10.2220/biomedres.37.199
|
|
6036
Suzuki T, Kasamatsu A, Miyamoto I, Saito T, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of TMOD1 is associated with enhanced regional lymph node metastasis in human oral cancer.
Int J Oncol.
2016
48(2):607-12
PubMed ID: 26718916
DOI: 10.3892/ijo.2015.3305
|
|
6042
Unozawa M, Kasamatsu A, Higo M, Fukumoto C, Koyama T, Sakazume T, Nakashima D, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa
Cavin-2 in oral cancer: A potential predictor for tumor progression.
Mol Carcinog
2016
55(6):1037-47
PubMed ID: 26086332
DOI: 10.1002/mc.22347
|
|
12933
Obayashi M, Yoshida M, Tsunematsu T, Ogawa I, Sasahira T, Kuniyasu H, Imoto I, Abiko Y, Xu D, Fukunaga S, Tahara H, Kudo Y, Nagao T, Takata T.
microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer
Oncotarget
2016
7(7):8223-39
PubMed ID: 26882562
DOI: 10.18632/oncotarget.6972
|
|
14162
Yamali C, Gul HI, Sakagami H, Supuran CT.
Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases
J Enzyme Inhib Med Chem
2016
31(sup4):125-131
PubMed ID: 27594305
DOI: 10.1080/14756366.2016.1221825
|
|
14178
Orabi MA, Taniguchi S, Sakagami H, Yoshimura M, Amakura Y, Hatano T.
Hydrolyzable Tannins of Tamaricaceous Plants. 7.1 Structures and Cytotoxic Properties of Oligomeric Ellagitannins from Leaves of Tamarix nilotica and Cultured Tissues of Tamarix tetrandra
J Nat Prod
2016
79(4):984-95
PubMed ID: 26938659
DOI: 10.1021/acs.jnatprod.5b01065
|
|
14581
Yasukawa M, Fujihara H, Fujimori H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Kishi Y, Hamada Y, Masutani M.
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
Int J Mol Sci
2016
17(3):272
PubMed ID: 26927065
DOI: 10.3390/ijms17030272
|
|
7196
Uesawa Y, Sakagami H, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Yahagi H, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 3-Styryl-2H-chromenes.
Anticancer Res.
2015
35:5299-307
PubMed ID: 26408690
|
|
7442
Shirako Y, Taya Y, Sato K, Chiba T, Imai K, Shimazu Y, Aoba T, Soeno Y.
Heterogeneous tumor stromal microenvironments of oral squamous cell carcinoma cells in tongue and nodal metastatic lesions in a xenograft mouse model.
J. Oral Pathol. Med.
2015
44:656-68
PubMed ID: 25765182
DOI: 10.1111/jop.12318
|
|
5422
Sakagami H, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Sugita Y5.
Quantitative Structure-Cytotoxicity Relationship of Oleoylamides.
Anticancer Res
2015
5(10):5341-51
PubMed ID: 26408695
|
|
6043
Sakagami H, Shimada C, Kanda Y, Amano O, Sugimoto M, Ota S, Soga T, Tomita M, Sato A, Tanuma SI, Takao K, Sugita Y.
Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells.
Toxicol Rep
2015
2:1281-1290
PubMed ID: 28962471
DOI: 10.1016/j.toxrep.2015.09.009
|
|
6044
Kasama H et al
Adenosine A2b receptor promotes progression of human oral cancer.
BMC Cancer
2015
15:563
PubMed ID: 26228921
DOI: 10.1186/s12885-015-1577-2
|
|
6051
Okamoto A et al
Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
PLoS One
2015
10(11):e0142252
PubMed ID: 26554377
DOI: 10.1371/journal.pone.0142252
|
|
6052
Saito T et al
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
PLoS One
2015
10(9):e0137923
PubMed ID: 26378920
DOI: 10.1371/journal.pone.0137923
|
|
6053
Miyamoto I et al
Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.
Biochem Biophys Rep
2015
3:26-31
PubMed ID: 29124166
DOI: 10.1016/j.bbrep.2015.07.008
|
|
6054
Baba T et al
Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
Mol Carcinog
2015
54(8):608-17
PubMed ID: 24375483
DOI: 10.1002/mc.22127
|
|
6058
Shida-Sakazume T et al
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
PLoS One.
2015
10(3):e0120143
PubMed ID: 25803864
DOI: 10.1371/journal.pone.0120143
|
|
15042
Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer
Cancer Med
2015
4(5):759-69
PubMed ID: 25644496
DOI: 10.1002/cam4.418
|
|
15186
Kumai T, Matsuda Y, Ohkuri T, Oikawa K, Ishibashi K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma
Oncoimmunology
2015
4(2):e976077
PubMed ID: 25949874
DOI: 10.4161/2162402X.2014.976077
|
|
6056
Suzuki R, Matsuno S, Sakagami H, Okada Y, Shirataki Y.
Search of new cytotoxic crude materials against human oral squamous cell carcinoma using 1H NMR-based metabolomics.
Anticancer Res
2014
34(8):4117-20
PubMed ID: 25075037
|
|
6040
Garcia-Contreras R, Scougall-Vilchis RJ, Contreras-Bulnes R, Ando Y, Kanda Y, Hibino Y, Nakajima H, Sakagami H.
Effects of TiO2 nanoparticles on cytotoxic action of chemotherapeutic drugs against a human oral squamous cell carcinoma cell line.
In Vivo
2014
28(2):209-15
PubMed ID: 24632975
|
|
6038
Hiroshi Sakagami et al
Metabolomic profiling of sodium fluoride-induced cytotoxicity in an oral squamous cell carcinoma cell line
Metabolomics
2014
10:270–279
DOI: 10.1007/s11306-013-0576-z
|
|
5916
Garcia-Contreras R, Scougall-Vilchis RJ, Contreras-Bulnes R, Kanda Y, Nakajima H, Sakagami H
Cytotoxicity and pro-inflammatory action of chemo-mechanical caries-removal agents against oral cells.
In Vivo
2014
28(4):549-56
PubMed ID: 24982221
|
|
5859
Miyamoto C, Maehata Y, Motohashi K, Ozawa S, Ikoma T, Hidaka K, Wada-Takahashi S, Takahashi SS, Yoshino F, Yoshida A, Kubota E, Hata R, Lee MC.
Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.
Biomed Res.
2014
35(6):381-8
PubMed ID: 25743344
DOI: 10.2220/biomedres.35.381
|
|
5807
Garcia-Contreras R, Scougall-Vilchis RJ, Contreras-Bulnes R, Kanda Y, Nakajima H, Sakagami H.
Effects of TiO2 nano glass ionomer cements against normal and cancer oral cells.
In Vivo
2014
28(5):895-907
PubMed ID: 25189906
|
|
5778
Ishige S, Kasamatsu A, Ogoshi K, Saito Y, Usukura K, Yokoe H, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.
Mol Carcinog
2014
53(7):557-65
PubMed ID: 23371469
DOI: 10.1002/mc.22007
|
|
5659
Shimada C, Uesawa Y, Ishii-Nozawa R, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Sugita Y, Sakagami H.
Quantitative structure-cytotoxicity relationship of 3-styrylchromones.
Anticancer Res
2014
34(10):5405-11
PubMed ID: 25275035
|
|
5605
Iizuka S, Oridate N, Nashimoto M, Fukuda S, Tamura M.
Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.
PLoS One
2014
9(12):e114121
PubMed ID: 25437003
DOI: 10.1371/journal.pone.0114121
|
|
5544
Shimada C, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Saito T, Sugita Y, Sakagami H.
Quantitative structure-cytotoxicity relationship of phenylpropanoid amides.
Anticancer Res
2014
34(7):3543-8
PubMed ID: 24982367
|
|
5337
Shimada C, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Miyashiro T, Sugita Y, Sakagami H.
Quantitative structure-cytotoxicity relationship of piperic acid amides.
Anticancer Res
2014
34(9):4877-84
PubMed ID: 25202069
|
|
5315
Sekine S, Shimodaira C, Uesawa Y, Kagaya H, Kanda Y, Ishihara M, Amano O, Sakagami H, Wakabayashi H.
Quantitative structure-activity relationship analysis of cytotoxicity and anti-UV activity of 2-aminotropones.
Anticancer Res
2014
4(4):1743-50
PubMed ID: 24692705
|
|
16010
Fukumoto C, Nakashima D, Kasamatsu A, Unozawa M, Shida-Sakazume T, Higo M, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice
Oncoscience
2014
1(12):807-20
PubMed ID: 25621296
DOI: 10.18632/oncoscience.101
|
|
5190
Yamamoto M, Fujita H, Katase N, Inoue K, Nagatsuka H, Utsumi K, Sasaki J, Ohuchi H.
Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Acta Med Okayama
2013
67(3):153-64
PubMed ID: 23804138
DOI: 10.18926/AMO/50408
|
|
5122
Iida S, Shimada J, Sakagami H.
Cytotoxicity induced by docetaxel in human oral squamous cell carcinoma cell lines.
In Vivo
2013
27(3):321-32
PubMed ID: 23606687
|
|
5110
Ohno H, Araho D, Uesawa Y, Kagaya H, Ishihara M, Sakagami H, Yamamoto M.
Evaluation of cytotoxiciy and tumor-specificity of licorice flavonoids based on chemical structure.
Anticancer Res
2013
33(8):3061-8
PubMed ID: 23898061
|
|
5028
Saito Y, Kasamatsu A, Yamamoto A, Shimizu T, Yokoe H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.
J Cancer Res Clin Oncol
2013
139(4):585-94
PubMed ID: 23242234
DOI: 10.1007/s00432-012-1361-5
|
|
6065
Miyazaki Y, Fujinami M, Inoue H, Kikuchi K, Ide F, Kusama K.
Expression of activation-induced cytidine deaminase in oral epithelial dysplasia and oral squamous cell carcinoma.
J Oral Sci
2013
55(4):293-9
PubMed ID: 24351917
DOI: 10.2334/josnusd.55.293
|
|
6067
Koike K, Kasamatsu A, Iyoda M, Saito Y, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Tanzawa H, Uzawa K.
High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
Int J Oncol
2013
42(1):141-50
PubMed ID: 23123766
DOI: 10.3892/ijo.2012.1677
|
|
6070
Yamamoto A, Kasamatsu A, Ishige S, Koike K, Saito K, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.
J Cancer Res Clin Oncol
2013
139(4):533-42
PubMed ID: 23207790
DOI: 10.1007/s00432-012-1356-2
|
|
6072
Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Tanzawa H.
Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
PLoS One
2013
8(2):e56381
PubMed ID: 23418564
DOI: 10.1371/journal.pone.0056381
|
|
6076
Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Kinesin family member 4A: a potential predictor for progression of human oral cancer.
PLoS One. 2
2013
8(12):e85951
PubMed ID: 24386490
DOI: 10.1371/journal.pone.0085951
|
|
6077
Mikami T, Hada T, Chosa N, Ishisaki A, Mizuki H, Takeda Y. Author information
Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
J Oral Pathol Med
2013
42(2):133-9
PubMed ID: 22672247
DOI: 10.1111/j.1600-0714.2012.01182.x
|
|
6078
Hotta H, Hamamura K, Yamashita K, Shibuya H, Tokuda N, Hashimoto N, Furukawa K, Yamamoto N, Hattori H, Toyokuni S, Ueda M, Furukawa K.
Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.
Glycoconj J
2013
30(6):585-97
PubMed ID: 23242548
DOI: 10.1007/s10719-012-9458-2
|
|
6081
Kimura R, Kasamatsu A, Koyama T, Fukumoto C, Kouzu Y, Higo M, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation.
BMC Cancer
2013
13:555
PubMed ID: 24261884
DOI: 10.1186/1471-2407-13-555
|
|
6083
Kumai T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
Br J Cancer
2013
109(8):2155-66
PubMed ID: 24045666
DOI: 10.1038/bjc.2013.577
|
|
15086
Katase N, Lefeuvre M, Tsujigiwa H, Fujii M, Ito S, Tamamura R, Buery RR, Gunduz M, Nagatsuka H.
Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells
Oncol Rep
2013
29(4):1349-55
PubMed ID: 23354949
DOI: 10.3892/or.2013.2251
|
|
16085
Ferdous T, Harada K, Kin T, Harada T, Ueyama Y.
Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells
Int J Oncol
2013
43(1):271-9
PubMed ID: 23695365
DOI: 10.3892/ijo.2013.1950
|
|
16313
Ohkoshi E Amano S
Efficient Utilization of Plant Resources by Alkaline Extraction
Alternative & Integrative Medicine
2013
02
DOI: 10.4172/2327-5162.1000133
|
|
6087
Miyazaki Y, Inoue H, Kikuchi K, Ochiai K, Kusama K.
Activation-induced cytidine deaminase mRNA expression in oral squamous cell carcinoma-derived cell lines is upregulated by inflammatory cytokines.
J Oral Sci
2012
54(1):71-5
PubMed ID: 22466889
DOI: 10.2334/josnusd.54.71
|
|
6088
Baba T, Kawaguchi M, Fukushima T, Sato Y, Orikawa H, Yorita K, Tanaka H, Lin CY, Sakoda S, Kataoka H.
Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
J Pathol
2012
228(2):181-92
PubMed ID: 22262311
DOI: 10.1002/path.3993
|
|
6089
Inoue H, Miyazaki Y, Kikuchi K, Yoshida N, Ide F, Ohmori Y, Tomomura A, Sakashita H, Kusama K.
Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
J Oral Sci
2012
54(3):241-50
PubMed ID: 23047035
DOI: 10.2334/josnusd.54.241
|
|
6091
Shimada E, Kataoka H, Miyazawa Y, Yamamoto M, Igarashi T.
Lipoproteins of Actinomyces viscosus induce inflammatory responses through TLR2 in human gingival epithelial cells and macrophages.
Microbes Infect
2012
14(11):916-21
PubMed ID: 22561467
DOI: 10.1016/j.micinf.2012.04.015
|
|
6095
Katase N, Lefeuvre M, Gunduz M, Gunduz E, Beder LB, Grenman R, Fujii M, Tamamura R, Tsujigiwa H, Nagatsuka H.
Absence of Dickkopf (Dkk)-3 protein expression is correlated with longer disease-free survival and lower incidence of metastasis in head and neck squamous cell carcinoma.
Oncol Lett
2012
3(2):273-280
PubMed ID: 22740894
DOI: 10.3892/ol.2011.473
|
|
6098
Inoue H, Miyazaki Y, Kikuchi K, Yoshida N, Ide F, Ohmori Y, Tomomura A, Sakashita H, Kusama K.
Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity.
Tumour Biol
2012
33(1):183-94
PubMed ID: 22081310
DOI: 10.1007/s13277-011-0261-7
|
|
15671
Harada T, Harada K, Ueyama Y.
The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma
Int J Oncol
2012
41(2):565-72
PubMed ID: 22664937
DOI: 10.3892/ijo.2012.1501
|
|
15740
Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M, Kawashiri S, Imai K.
Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch
PLoS One
2012
7(10):e4789
PubMed ID: 23110125
DOI: 10.1371/journal.pone.0047899
|
|
7601
Uesawa Y, Mohri K, Kawase M, Ishihara M, Sakagami H.
Quantitative structure-activity relationship (QSAR) analysis of tumor-specificity of 1,2,3,4-tetrahydroisoquinoline derivatives.
Anticancer Res.
2011
31:4231-8
PubMed ID: 22199286
|
|
7764
Otsuki S, Sugiyama K, Amano O, Yasui T, Sakagami H.
Negative regulation of NaF-induced apoptosis by Bad-CAII complex.
Toxicology
2011
287:131-6
PubMed ID: 21708216
DOI: 10.1016/j.tox.2011.06.007
|
|
7967
Iwasaka K, Tomita K, Ozawa Y, Katayama T, Sakagami H.
Effect of CO2 laser irradiation on hormesis induction in cultured oral cells.
In Vivo
2011
25:93-8
PubMed ID: 21282740
|
|
5323
Jitsuno M, Yokosuka A, Hashimoto K, Amano O, Sakagami H, Mimaki Y.
Chemical constituents of Lycoris albiflora and their cytotoxic activities.
Nat Prod Commun
2011
6(2):187-92
PubMed ID: 21425671
|
|
6116
Zhang T, Hamada K, Hyodo M, Itoh H, Tani K, Goda H, Nakashiro K, Hamakawa H.
Gene therapy for oral squamous cell carcinoma with IAI.3B promoter-driven oncolytic adenovirus-infected carrier cells.
Oncol Rep
2011
25(3):795-802
PubMed ID: 21206983
DOI: 10.3892/or.2010.1130
|
|
8085
Sakagami H, Zhou L, Kawano M, Thet MM, Tanaka S, Machino M, Amano S, Kuroshita R, Watanabe S, Chu Q, Wang QT, Kanamoto T, Terakubo S, Nakashima H, Sekine K, Shirataki Y, Zhang CH, Uesawa Y, Mohri K, Kitajima M, Oizumi H, Oizumi T.
Multiple biological complex of alkaline extract of the leaves of Sasa senanensis Rehder.
In Vivo
2010
24:735-43
PubMed ID: 20952742
|
|
8406
Okugawa T, Kaneko T, Yoshimura A, Silverman N, Hara Y.
NOD1 and NOD2 mediate sensing of periodontal pathogens.
J. Dent. Res.
2010
89:186-91
PubMed ID: 20040739
DOI: 10.1177/0022034509354843
|
|
5611
Wakabayashi H, Narita T, Suga A, Sakagami H.
Hormetic response of cultured normal and tumor cells to 2-aminotropone derivatives.
In Vivo
2010
24(1):39-44
PubMed ID: 20133973
|
|
6119
Okahashi N, Nakata M, Sakurai A, Terao Y, Hoshino T, Yamaguchi M, Isoda R, Sumitomo T, Nakano K, Kawabata S, Ooshima T.
Pili of oral Streptococcus sanguinis bind to fibronectin and contribute to cell adhesion.
Biochem Biophys Res Commun
2010
391(2):1192-6
PubMed ID: 20004645
DOI: 10.1016/j.bbrc.2009.12.029
|
|
6120
Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Biochem Biophys Res Commun
2010
391(4):1785-91
PubMed ID: 20045673
DOI: 10.1016/j.bbrc.2009.12.156
|
|
6122
Nomi N, Kodama S, Suzuki M.
Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway.
Oncol Rep
2010
24(1):225-31
PubMed ID: 20514466
DOI: 10.3892/or_00000850
|
|
6123
Yuji Miyazaki et al
Association of butyric acid produced by periodontopathic bacteria with progression of oral cancer
J Cancer Sci Ther
2010
2(2) :26-32
|
|
6127
Hatano H, Takekawa F, Hashimoto K, Ishihara M, Kawase M, Qing C, Qin-Tao W, Sakagami H.
Tumor-specific cytotoxic activity of 1,2,3,4-tetrahydroisoquinoline derivatives against human oral squamous cell carcinoma cell lines.
Anticancer Res
2009
29(8):3079-86
PubMed ID: 19661319
|
|
6128
Takano A, Hashimoto K, Ogawa M, Koyanagi J, Kurihara T, Wakabayashi H, Kikuchi H, Nakamura Y, Motohashi N, Sakagami H, Yamamoto K, Tanaka A.
Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure.
Anticancer Res
2009
29(1):455-64
PubMed ID: 19331186
|
|
6129
Narita T, Suga A, Kobayashi M, Hashimoto K, Sakagami H, Motohashi N, Kurihara T, Wakabayashi H.
Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives.
Anticancer Res
2009
29(4):1123-30
PubMed ID: 19414354
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
6136
Okamura M, Shimada J, Sakagami H.
Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Anticancer Res
2008
28(1A):253-9
PubMed ID: 18383853
|
|
6138
Murayama H, Miyahara K, Wakabayashi H, Kurihara T, Hashimoto K, Amano O, Kikuchi H, Nakamura Y, Kanda Y, Kunii S, Motohashi N, Sakagami H.
Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines.
Anticancer Res
2008
28(2A):1069-78
PubMed ID: 18507056
|
|
6141
Nakamura E, Kozaki K, Tsuda H, Suzuki E, Pimkhaokham A, Yamamoto G, Irie T, Tachikawa T, Amagasa T, Inazawa J, Imoto I.
Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
Cancer Sci
2008
99(7):1390-400
PubMed ID: 18452558
DOI: 10.1111/j.1349-7006.2008.00838.x
|
|
6142
Okamura M, Kobayashi M, Suzuki F, Shimada J, Sakagami H.
Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line.
Anticancer Res
2007
27(5A):3331-7
PubMed ID: 17970078
|
|
6143
Sekine T, Takahashi J, Nishishiro M, Arai A, Wakabayashi H, Kurihara T, Kobayashi M, Hashimoto K, Kikuchi H, Katayama T, Kanda Y, Kunii S, Motohashi N, Sakagami H.
Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
Anticancer Res.
2007
27(1A):133-43
PubMed ID: 17352225
|
|
6148
Akatsu Y, Ohshima N, Yamagishi Y, Nishishiro M, Wakabayashi H, Kurihara T, Kikuchi H, Katayama T, Motohashi N, Shoji Y, Nakashima H, Sakagami H.
Apoptosis-inducing activity of trihaloacetylazulenes against human oral tumor cell lines.
Anticancer Res
2006
26(3A):1917-23
PubMed ID: 16827125
|
|
6150
Ichwan SJ, Yamada S, Sumrejkanchanakij P, Ibrahim-Auerkari E, Eto K, Ikeda MA.
Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.
Oncogene
2006
25(8):1216-24
PubMed ID: 16247456
DOI: 10.1038/sj.onc.1209158
|
|
6152
Wakabayashi H, Nishishiro M, Arikawa S, Hashimoto K, Kikuchi H, Nishikawa H, Kurihara T, Terakubo S, Shoji Y, Nakashima H, Motohashi N, Sakagami H.
Cytotoxic activity of azulenequinones against human oral tumor cell lines.
Anticancer Res
2005
25(1A):305-12
PubMed ID: 15816552
|
Back
Top
CELL BANK Website
